Given the aforementioned findings, we performed the current study aiming to ascertain the effect of miR-224-5p on the airway inflammation in asthma, which involved FHL1 and the MAPK pathway (Additional file 1: Fig. S1). This evidence concerns the gene FHL1 and asthma.